<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>A1C over time in type 2 diabetes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">A1C over time in type 2 diabetes</h1>
<div class="graphic"><div class="figure"><div class="ttl">A1C over time in type 2 diabetes</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Mean A1C levels in patients with type 2 diabetes on metformin monotherapy who were randomly assigned to add-on treatment with sitagliptin (red line), glimepiride (orange line), liraglutide (blue line), or glargine (black line).</div><div class="graphic_footnotes">A1C: glycated hemoglobin.</div><div class="graphic_reference">From: The GRADE Study Research Group. Glycemia Reduction in Type 2 Diabetes — Glycemic Outcomes. N Engl J Med 2022; 387:1063. Copyright © 2022 Massachusetts Medical Society. Reprinted with permission from Massachusetts Medical Society.</div><div id="graphicVersion">Graphic 139800 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
